After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical ...

A team from the Spanish National Cancer Research Centre (CNIO) has discovered a novel way in which tumor cells alter the ...

After you’re diagnosed with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer, your doctor’s goal is to build a treatment plan that gives you the best chance of controlling your ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence - a ...

Phase 2 TBCRC049 trial results show tucatinib triplet therapy improves survival in HER2+ breast cancer patients with ...

For many, a stage 4 breast cancer diagnosis can feels scary, but Casey Liening is rewriting that narrative. After a two-year ...

Bladder cancer can cause pain when it spreads to different areas of the body. From NSAIDs to nerve blocks, here are the ...

Novocure today announced positive findings from a study of its tumor treating fields (TTFields) in metastatic pancreatic ...

For prostate cancer patients with low-volume tumors and metastasis, the median overall survival was 37.13 months. Prostate cancer patients with metastatic disease and low-volume primary tumors appear ...